BeiGene to Present at Upcoming Investor Conferences
June 07 2017 - 4:15PM
BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical
company developing innovative molecularly targeted and
immuno-oncology drugs for the treatment of cancer, today announced
that the company will present at the following upcoming investor
conferences:
William Blair 37th Annual Growth Stock
ConferenceDate: Tuesday, June 13, 2017Time: 12:50 PM CT
(1:50 PM ET)Location: Chicago, IL
Goldman Sachs 38th Annual Global Healthcare
ConferenceDate: Tuesday, June 13, 2017Time: 2:40 PM PT
(5:40 PM ET)Location: Ranchos Palos Verdes, CA
Live webcasts of the presentations can be accessed
from the investors section of BeiGene’s website at
http://ir.beigene.com/. An archived replay will be available for 90
days following the event.
About BeiGene
BeiGene is a global, clinical-stage, research-based
biotechnology company focused on molecularly targeted and
immuno-oncology cancer therapeutics. With a team of over 400
employees in mainland China, the United States, and Australia,
BeiGene is advancing a pipeline consisting of novel oral small
molecules and monoclonal antibodies for the treatment of cancer.
BeiGene is working to create combination solutions aimed at having
both a meaningful and lasting impact on cancer patients.
Investor/Media Contact
Lucy Li, Ph.D.
+1 781-801-1800
ir@beigene.com
media@beigene.com
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Aug 2024 to Sep 2024
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Sep 2023 to Sep 2024